# PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)

Study · id `cardio:ct-nct06542393` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06542393](<https://clinicaltrials.gov/study/NCT06542393>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06542393

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT06542393. Randomized; double masking; primary purpose treatment. Start 2024-06-01 (actual); primary completion 2025-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT06542393, source copy `cardio:ctgov-nct06542393-2024-08-07`, retrieved 2026-10-26)
- Started: 2024-06-01 (actual) (ClinicalTrials.gov record NCT06542393, source copy `cardio:ctgov-nct06542393-2024-08-07`, retrieved 2026-10-26)
- Primary completion: 2025-06-01 (anticipated) (ClinicalTrials.gov record NCT06542393, source copy `cardio:ctgov-nct06542393-2024-08-07`, retrieved 2026-10-26)
- Completion: 2026-06-01 (anticipated) (ClinicalTrials.gov record NCT06542393, source copy `cardio:ctgov-nct06542393-2024-08-07`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT06542393, source copy `cardio:ctgov-nct06542393-2024-08-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06542393-2024-08-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)
- Condition: Anemia
- Condition: Coronary Disease
- Condition: Coronary Artery Disease
- Condition: Coronary Stenosis
- Condition: Coronary Occlusion
- Condition: Systemic Inflammatory Response
- Condition: Bleeding
- Condition: Epigenetic Disorder
- Intervention (Drug): Erythropoietin
- Intervention (Procedure): blood transfusion
- Lead sponsor: Federal University of São Paulo
- Lead sponsor class: OTHER
- Collaborator: Fundação de Amparo à Pesquisa do Estado de São Paulo
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Federal University of São Paulo (`cardio:org-federal-university-of-sao-paulo`)
- Registry lists this organization as a collaborator: Fundação de Amparo à Pesquisa do Estado de São Paulo (`cardio:org-fundacao-de-amparo-a-pesquisa-do-estado-de-sao-paulo`)

## Provenance

Content hash: 4b58d8f239bb018fc186e090709a641c389ac5faed8c6fdeb77486c5aefc9810
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
